Zhaowei Gu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhaowei Gu has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Zhiwei Cao
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang City, People’s Republic of China
10 shared publicationsHe Zhao
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, PR China
8 shared publications- Yunxiu Wang
Department of Clinical Trial Ward, Clinical Trial and Conversion Center, Shengjing Hospital of China Medical University, Shenyang 110004, PR China; Department of Clinical Epidemiology, Clinical Research Center, Shengjing Hospital of China Medical University, Shenyang 110004, PR China; Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang 110122, PR China
7 shared publications Yunxiu Wang
Department of Clinical Trial Ward, Clinical Trial and Conversion Center, Shengjing Hospital of China Medical University, Shenyang, China
6 shared publicationsMeng Wang
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang City, People’s Republic of China
4 shared publicationsJing Yang
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, PR China
3 shared publications
Latest Publications
- 28 July 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 187, 117192
Dual role of macrophage heterogeneity in allergic inflammation: from mechanism to targeted therapy
- 28 July 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 187, 117192
Dual role of macrophage heterogeneity in allergic inflammation: from mechanism to targeted therapy
- 6 July 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 186, 117112
Macrophage autophagy in allergic diseases: Regulatory mechanisms, immune crosstalk, and therapeutic implications
- 6 July 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 186, 117112
Macrophage autophagy in allergic diseases: Regulatory mechanisms, immune crosstalk, and therapeutic implications
- Open Access
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Allergy
- Vol. 7, 1806555
The relationship between allergic rhinitis and sleep disorders and mental health
Allergic Rhinitis (AR) is a highly prevalent IgE-mediated chronic inflammatory disease of the nasal mucosa worldwide. Its incidence is continuously increasing and has become one of the important chronic diseases affecting public health. Recent studies have gradually revealed that AR not only presents with local symptoms such as nasal congestion, runny nose, sneezing, and nasal itching, but is also closely related to a wide range of physical and mental health problems, especially mental and psychological disorders (such as anxiety and depression) and decreased sleep quality. There is a complex two-way or even circular interaction between these three factors. This article systematically reviews the epidemiological characteristics and pathophysiological mechanisms of AR, and focuses on exploring the association pathways and potential mechanisms between AR and mental health as well as sleep disorders, including neuroimmune regulation (such as inflammatory mediators, HPA axis function), psychological and behavioral factors, and social function impairment. Based on this, the article further summarizes the assessment tools and multimodal intervention strategies for mental and psychological problems and sleep disorders in AR patients, covering drug treatment, psychotherapy, sleep hygiene education, and comprehensive health management, etc. This article integrates current evidence and provides a theoretical framework for a comprehensive understanding of the multi-dimensional impact of AR, and offers references for comprehensive assessment and individualized intervention in clinical practice.
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Allergy
- Vol. 7, 1806555
Open AccessThe relationship between allergic rhinitis and sleep disorders and mental health
Allergic Rhinitis (AR) is a highly prevalent IgE-mediated chronic inflammatory disease of the nasal mucosa worldwide. Its incidence is continuously increasing and has become one of the important chronic diseases affecting public health. Recent studies have gradually revealed that AR not only presents with local symptoms such as nasal congestion, runny nose, sneezing, and nasal itching, but is also closely related to a wide range of physical and mental health problems, especially mental and psychological disorders (such as anxiety and depression) and decreased sleep quality. There is a complex two-way or even circular interaction between these three factors. This article systematically reviews the epidemiological characteristics and pathophysiological mechanisms of AR, and focuses on exploring the association pathways and potential mechanisms between AR and mental health as well as sleep disorders, including neuroimmune regulation (such as inflammatory mediators, HPA axis function), psychological and behavioral factors, and social function impairment. Based on this, the article further summarizes the assessment tools and multimodal intervention strategies for mental and psychological problems and sleep disorders in AR patients, covering drug treatment, psychotherapy, sleep hygiene education, and comprehensive health management, etc. This article integrates current evidence and provides a theoretical framework for a comprehensive understanding of the multi-dimensional impact of AR, and offers references for comprehensive assessment and individualized intervention in clinical practice.
- Open Access
- 30 March 2026
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 42 (1)
Regulation of m6A modifications in Th2-driven allergic responses: impact on responses and therapeutic potential
Th2-driven allergic responses are characterized by allergic reactions and immune dysregulation with complex pathogenesis that warrants urgent in-depth study. The predominant posttranscriptional modification observed in eukaryotic messenger RNAs, N6-methyladenosine (m6A), dynamically regulates RNA splicing, which is likely regulated during cell fate determination, cytokine production, and epithelial barrier maintenance in context of Th2-driven allergic responses. This review systematically analyzes the effects of m6A modification on the differentiation and functional regulation of major immune cell populations, including dendritic cells, macrophages, T helper cells, B cells, and mast cells, as well as barrier-forming epithelial cells. Additionally, we discuss how m6A regulators control the transcription of cytokine-encoding genes, transcription factors that regulate T-cell function, and T lymphocyte activation signals. Furthermore, this paper integrates the latest research advancements and explores the application potential of m6A modification for diagnosis and treatment of Th2-driven allergic disorders, including allergic asthma and rhinitis. By presenting a summary of the current progress in this area of research, this paper aims at summarizing the role of m6A modification during Th2-driven allergic responses and highlight its therapeutic potential and future research directions. Graphical Abstract
- 30 March 2026
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 42 (1)
Open AccessRegulation of m6A modifications in Th2-driven allergic responses: impact on responses and therapeutic potential
Th2-driven allergic responses are characterized by allergic reactions and immune dysregulation with complex pathogenesis that warrants urgent in-depth study. The predominant posttranscriptional modification observed in eukaryotic messenger RNAs, N6-methyladenosine (m6A), dynamically regulates RNA splicing, which is likely regulated during cell fate determination, cytokine production, and epithelial barrier maintenance in context of Th2-driven allergic responses. This review systematically analyzes the effects of m6A modification on the differentiation and functional regulation of major immune cell populations, including dendritic cells, macrophages, T helper cells, B cells, and mast cells, as well as barrier-forming epithelial cells. Additionally, we discuss how m6A regulators control the transcription of cytokine-encoding genes, transcription factors that regulate T-cell function, and T lymphocyte activation signals. Furthermore, this paper integrates the latest research advancements and explores the application potential of m6A modification for diagnosis and treatment of Th2-driven allergic disorders, including allergic asthma and rhinitis. By presenting a summary of the current progress in this area of research, this paper aims at summarizing the role of m6A modification during Th2-driven allergic responses and highlight its therapeutic potential and future research directions. Graphical Abstract
- 5 May 2025
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 68 (1) , 1-14
Mechanisms and Therapeutic Implications of EZH2 in Nasal Diseases
Enhancer of zeste homolog 2 (EZH2), a protein encoded by the EZH2 gene, is a crucial subunit in polycomb repressive complex 2. EZH2 controls the transcription of genes critical for cell proliferation, differentiation, amplification, and function through both methylated and unmethylated functions. EZH2 is considered to be a transcriptional suppressor protein when it controls histone methylation. Its dysregulation is related to a variety of cancers, with significant evidence showing its role in prostate cancer and breast cancer. EZH2 is also thought to be involved in the differentiation and function of immune cells. Ongoing research on EZH2 has revealed the correlation between inflammatory nasal diseases, the occurrence and development of nasal sinus tumors, and EZH2. This article aimed to review the research progress on the role of EZH2 in nasal diseases and explore the possibility of future EZH2-targeted therapies for nasal diseases.
- 5 May 2025
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 68 (1) , 1-14
Mechanisms and Therapeutic Implications of EZH2 in Nasal Diseases
Enhancer of zeste homolog 2 (EZH2), a protein encoded by the EZH2 gene, is a crucial subunit in polycomb repressive complex 2. EZH2 controls the transcription of genes critical for cell proliferation, differentiation, amplification, and function through both methylated and unmethylated functions. EZH2 is considered to be a transcriptional suppressor protein when it controls histone methylation. Its dysregulation is related to a variety of cancers, with significant evidence showing its role in prostate cancer and breast cancer. EZH2 is also thought to be involved in the differentiation and function of immune cells. Ongoing research on EZH2 has revealed the correlation between inflammatory nasal diseases, the occurrence and development of nasal sinus tumors, and EZH2. This article aimed to review the research progress on the role of EZH2 in nasal diseases and explore the possibility of future EZH2-targeted therapies for nasal diseases.
- Open Access
- 1 November 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 181, 117655
The role and mechanism of extracellular traps in chronic rhinosinusitis
- 1 November 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 181, 117655
Open AccessThe role and mechanism of extracellular traps in chronic rhinosinusitis
- Open Access
- 24 June 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 177, 117019
Effect of IL-9 neutralising antibody on pyroptosis via SGK1/NF-κB/NLRP3/GSDMD in allergic rhinitis mice
- 24 June 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 177, 117019
Open AccessEffect of IL-9 neutralising antibody on pyroptosis via SGK1/NF-κB/NLRP3/GSDMD in allergic rhinitis mice
- Open Access
- 19 January 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1283465
Ferroptosis in head and neck squamous cell carcinoma: from pathogenesis to treatment
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignant tumor worldwide, with high morbidity and mortality. Surgery and postoperative chemoradiotherapy have largely reduced the recurrence and fatality rates for most HNSCCs. Nonetheless, these therapeutic approaches result in poor prognoses owing to severe adverse reactions and the development of drug resistance. Ferroptosis is a kind of programmed cell death which is non-apoptotic. Ferroptosis of tumor cells can inhibit tumor development. Ferroptosis involves various biomolecules and signaling pathways, whose expressions can be adjusted to modulate the sensitivity of cells to ferroptosis. As a tool in the fight against cancer, the activation of ferroptosis is a treatment that has received much attention in recent years. Therefore, understanding the molecular mechanism of ferroptosis in HNSCC is an essential strategy with therapeutic potential. The most important thing to treat HNSCC is to choose the appropriate treatment method. In this review, we discuss the molecular and defense mechanisms of ferroptosis, analyze the role and mechanism of ferroptosis in the inhibition and immunity against HNSCC, and explore the therapeutic strategy for inducing ferroptosis in HNSCC including drug therapy, radiation therapy, immunotherapy, nanotherapy and comprehensive treatment. We find ferroptosis provides a new target for HNSCC treatment.
- 19 January 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1283465
Open AccessFerroptosis in head and neck squamous cell carcinoma: from pathogenesis to treatment
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignant tumor worldwide, with high morbidity and mortality. Surgery and postoperative chemoradiotherapy have largely reduced the recurrence and fatality rates for most HNSCCs. Nonetheless, these therapeutic approaches result in poor prognoses owing to severe adverse reactions and the development of drug resistance. Ferroptosis is a kind of programmed cell death which is non-apoptotic. Ferroptosis of tumor cells can inhibit tumor development. Ferroptosis involves various biomolecules and signaling pathways, whose expressions can be adjusted to modulate the sensitivity of cells to ferroptosis. As a tool in the fight against cancer, the activation of ferroptosis is a treatment that has received much attention in recent years. Therefore, understanding the molecular mechanism of ferroptosis in HNSCC is an essential strategy with therapeutic potential. The most important thing to treat HNSCC is to choose the appropriate treatment method. In this review, we discuss the molecular and defense mechanisms of ferroptosis, analyze the role and mechanism of ferroptosis in the inhibition and immunity against HNSCC, and explore the therapeutic strategy for inducing ferroptosis in HNSCC including drug therapy, radiation therapy, immunotherapy, nanotherapy and comprehensive treatment. We find ferroptosis provides a new target for HNSCC treatment.
- 2 January 2024
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 184, 114435
Exposure of nonylphenol promoted NLRP3 inflammasome and GSDMD-mediated pyroptosis in allergic rhinitis mice
- 2 January 2024
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 184, 114435
Exposure of nonylphenol promoted NLRP3 inflammasome and GSDMD-mediated pyroptosis in allergic rhinitis mice
- 20 November 2023
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 35 (1) , e96-e98
Endoscopic Repair of Cerebrospinal Fluid Rhinorrhea Due to Trauma by a Bamboo Stick in a Pediatric Patient
Cerebrospinal fluid rhinorrhea (CSFR) is a condition in which the cerebrospinal fluid flows out of the nasal cavity due to rupture of the arachnoid, dura, and nasal membranes because of bone defects in the skull base. The authors report a rare case of CSFR in a 2-year-old girl who experienced trauma in the nasal cavity by a bamboo stick. She underwent endoscopic repair for the CSFR. During surgery, a bulged vesicle was observed at the left cribriform plate with a small amount of cerebrospinal fluid draining from the surrounding area. Postoperative recovery was good. Endoscopic CSFR repair in pediatric patients is minimally invasive, effective, and safe as demonstrated in this case. Prevention of CSFR in children is important. Parents and caretakers of children need to be more aware, and potentially dangerous objects should not be kept within reach of children.
- 20 November 2023
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 35 (1) , e96-e98
Endoscopic Repair of Cerebrospinal Fluid Rhinorrhea Due to Trauma by a Bamboo Stick in a Pediatric Patient
Cerebrospinal fluid rhinorrhea (CSFR) is a condition in which the cerebrospinal fluid flows out of the nasal cavity due to rupture of the arachnoid, dura, and nasal membranes because of bone defects in the skull base. The authors report a rare case of CSFR in a 2-year-old girl who experienced trauma in the nasal cavity by a bamboo stick. She underwent endoscopic repair for the CSFR. During surgery, a bulged vesicle was observed at the left cribriform plate with a small amount of cerebrospinal fluid draining from the surrounding area. Postoperative recovery was good. Endoscopic CSFR repair in pediatric patients is minimally invasive, effective, and safe as demonstrated in this case. Prevention of CSFR in children is important. Parents and caretakers of children need to be more aware, and potentially dangerous objects should not be kept within reach of children.